ORIGINAL PAPER
Widespread headache as the first clinical manifestation of giant cell arteritis in patients affected by polymyalgia rheumatica
Submission date: 2016-10-02
Final revision date: 2016-10-28
Acceptance date: 2016-10-31
Online publication date: 2016-11-28
Publication date: 2016-10-28
Reumatologia 2016;54(5):236-238
KEYWORDS
TOPICS
Vasculitis - aetiology, pathogenesis, clinical features and treatmentReports, books reviews, commentaries
ABSTRACT
Introduction: In giant cell arteritis (GCA) headache of new onset due to inflammatory involvement of the temporal artery (TA) represents a diagnostic criterion. A widespread headache (WH) with scalp tenderness due to cranial arteritis can represent another manifestation of GCA.
Material and methods: In 225 elderly patients with polymyalgia rheumatica (PMR) followed in our rheumatologic outpatient clinic from 2004 until June 2016, the frequency of WH as the first clinical manifestation of GCA was evaluated.
Results: Among 26 patients with GCA+PMR (11.6% of total) , 5 (23.07%) had WH as first clinical manifestation of GCA without TA. In all these patients TA colour duplex sonography (CDS) and 18-fluorodeoxyglucose positron emission tomography (FDG-PET) with total body contrast-enhanced CT was consistent with the diagnosis of arteritis. TA biopsy was not performed. High doses of prednisone (1 mg/kg/day) led to the immediate and total disappearance of the headache.
Conclusions: The widespread headache should be considered as the first symptom GCA and in cases of suspicion of vasculitis patients should have a full diagnostics examination. Colour duplex sonography and FDG-PET with total body contrast-enhanced CT are useful tools for non-invasive diagnosis of GCA.
Material and methods: In 225 elderly patients with polymyalgia rheumatica (PMR) followed in our rheumatologic outpatient clinic from 2004 until June 2016, the frequency of WH as the first clinical manifestation of GCA was evaluated.
Results: Among 26 patients with GCA+PMR (11.6% of total) , 5 (23.07%) had WH as first clinical manifestation of GCA without TA. In all these patients TA colour duplex sonography (CDS) and 18-fluorodeoxyglucose positron emission tomography (FDG-PET) with total body contrast-enhanced CT was consistent with the diagnosis of arteritis. TA biopsy was not performed. High doses of prednisone (1 mg/kg/day) led to the immediate and total disappearance of the headache.
Conclusions: The widespread headache should be considered as the first symptom GCA and in cases of suspicion of vasculitis patients should have a full diagnostics examination. Colour duplex sonography and FDG-PET with total body contrast-enhanced CT are useful tools for non-invasive diagnosis of GCA.
REFERENCES (18)
1.
Weyand CM, Goronzy JJ. Medium- and large-vessel vasculitis. N Engl J Med 2003; 349: 160-169.
2.
Salvarani C, Cantini F, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. Lancet 2008; 372: 234-245.
3.
Hunder GG, Bloch DA, Michel BA, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990 ; 33: 1122-1128.
4.
Kermani TA, Schmidt J, Crowson CS, et al. Utility of erythrocyte sedimentation rate and C-reactive protein for the diagnosis of giant cell arteritis. Semin Arthritis Rheum 2012; 41: 866-871.
5.
Helliwell T, Muller S, Hider S. ESR can be normal in giant cell arteritis and polymyalgia rheumatica. BMJ 2012; 344: e1408.
6.
Martínez-Taboada VM, Blanco R, Armona J, et al. Giant cell arteritis with an erythrocyte sedimentation rate lower than 50. Clin Rheumatol 2000; 19: 73-75.
7.
Muratore F, Cavazza A, Boiardi L, et al. Histopathologic findings of patients with biopsy-negative giant cell arteritis compared to those without arteritis: a population-based study. Arthritis Care Res (Hoboken) 2016; 68: 865-870.
8.
Laria A, Zoli A, Bocci M, et al. Systematic review of the literature and a case report informing biopsy-proven giant cell arteritis (GCA) with normal C-reactive protein. Clin Rheumatol 2012; 31: 1389-1393.
9.
Mukhtyar C, Guillevin L, Cid MC, et al. EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis 2009; 68: 318-323.
10.
Schmidt WA, Kraft HE, V¨olker L, et al. Colour Doppler sonography to diagnose temporal arteritis. Lancet 1995; 345: 8669.
11.
Ball AL, Walsh SR, Tang TY, et al. Role of ultrasonography in the diagnosis of temporal arteritis. Br J Surg 2010; 97: 1765-1771.
12.
Schmidt WA, Seifert A, Gromnica-Ihle E, et al. Ultrasound of proximal upper extremity arteries to increase the diagnostic yield in large-vessel giant cell arteritis. Rheumatology 2008; 47: 96-101.
13.
Diamantopoulos AP, Haugeberg G, Lindland A, Myklebust G. The fast-track ultrasound clinic for early diagnosis of giant cell arteritis significantly reduces permanent visual impairment: towards a more effective strategy to improve clinical outcome in giant cell arteritis? Rheumatology (Oxford) 2016; 55: 66-70.
14.
Schmidt WA. Ultrasound in vasculitis. Clin Exp Rheumatol 2014 ; 32 (1 Suppl 80): S71-S77.
15.
Henes JC, Müller M, Krieger J, et al. [18F] FDG-PET/CT as a new and sensitive imaging method for the diagnosis of large-vessel vasculitis. Clin Exp Rheum 2008; 26 suppl 49: S47-S52.
16.
Headache classification committee of the International Headache Society (IHS). Cephalalgia 2013; 33: 629-808.
17.
Rana AQ, Saeed U, Khan OA, et al. Giant cell arteritis or tension-type headache? A differential diagnostic dilemma. J Neurosci Rural Pract 2014; 5: 409-411.
18.
Ruiz M, Pedraza MI, de la Cruz C, et al. Headache in the elderly: characteristics in a series of 262 patients. Neurologia 2014; 29: 321-326.
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Share
RELATED ARTICLE
| eISSN: | 2084-9834 |
| ISSN: | 0034-6233 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
